Article
In vivo differentiated human embryonic stem cells can acquire chromosomal aberrations more frequently than in vitro during the same period.
Stem cells and development - 10 Dec 2012
Zucchelli Marco, Ström Susanne, Holm Frida, Malmgren Helena, Sahlén Sigrid, Religa Piotr, Hovatta Outi, Kere Juha, Inzunza José
Abstract excerpt
Human embryonic stem cells (hESCs) are regarded as a promising approach to generate transplantable cells for the treatment of several diseases. These cells offer an immense potential as a source of cells for regenerative medicine, but the possible ability of these cells to produce tumors in vivo presents a major impediment for the achievement of this potential in clinical reality. hESCs can obtain growth...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
